Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751127 · ClinicalTrials.gov registry record · Phase 3
A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
NCT00751127 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 268 participants.
The verdict
NCT00751127, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
Study Summary
PhXA41 is not inferior to timolol
Interventions
- DRUG PhXA41
- DRUG timolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 1993-01 |
| Est. Completion | 1994-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00751127
The ClinicalTrials.gov registry entry for NCT00751127 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PhXA41 is the first listed.
NCT00751127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00751127 about?
NCT00751127 is a clinical study titled "A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension". PhXA41 is not inferior to timolol
What is the current status of trial NCT00751127?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 1993-01. Estimated completion is 1994-02.
What interventions are being tested in trial NCT00751127?
The interventions under investigation include: PhXA41 (DRUG), timolol (DRUG).
Who is sponsoring clinical trial NCT00751127?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.